• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy.

作者信息

Reddy M S, Carmody T J, Kereiakes D J

机构信息

Department of Cardiology, Good Samaritan Hospital/Wright State University, Dayton, Ohio, USA.

出版信息

Catheter Cardiovasc Interv. 2001 Apr;52(4):486-8. doi: 10.1002/ccd.1108.

DOI:10.1002/ccd.1108
PMID:11285605
Abstract

Acute thrombocytopenia associated with abciximab therapy has been well described, although the exact mechanism remains obscure. We report a case of delayed severe thrombocytopenia associated with abciximab therapy for percutaneous coronary intervention that occurred following hospital discharge. The detection of this phenomenon is important as it may portend heightened risk for severe or profound thrombocytopenia on subsequent reexposure to abciximab therapy.

摘要

相似文献

1
Severe delayed thrombocytopenia associated with abciximab (ReoPro) therapy.
Catheter Cardiovasc Interv. 2001 Apr;52(4):486-8. doi: 10.1002/ccd.1108.
2
Acute profound thrombocytopenia without bleeding complications after re-administration of abciximab.再次使用阿昔单抗后出现急性严重血小板减少症且无出血并发症
J Invasive Cardiol. 2001 Jan;13(1):56-8.
3
Severe thrombocytopenia after an infusion of abciximab.
Haematologica. 2001 Mar;86(3):E05.
4
Abciximab readministration.阿昔单抗再次给药。
Rev Cardiovasc Med. 2002 Spring;3(2):67-70.
5
Clinical correlates and course of thrombocytopenia during percutaneous coronary intervention in the era of abciximab platelet glycoprotein IIb/IIIa blockade.在阿昔单抗血小板糖蛋白IIb/IIIa阻断时代，经皮冠状动脉介入治疗期间血小板减少症的临床关联及病程
Am Heart J. 2000 Jul;140(1):74-80. doi: 10.1067/mhj.2000.106615.
6
Profound delayed thrombocytopenia presenting 16 days after Abciximab (Reopro®) administration.阿昔单抗（Reopro®）给药 16 天后出现严重迟发性血小板减少症。
Platelets. 2011;22(4):302-4. doi: 10.3109/09537104.2010.518324. Epub 2011 Apr 28.
7
Delayed immune-mediated thrombocytopenia after re-exposure to abciximab therapy.再次接触阿昔单抗治疗后发生的免疫介导的血小板减少症延迟发作。
Can J Cardiol. 2011 Nov-Dec;27(6):869.e13-4. doi: 10.1016/j.cjca.2011.05.011. Epub 2011 Sep 1.
8
Profound thrombocytopenia caused by abciximab infusion following.随后因阿昔单抗输注导致严重血小板减少症。
Minn Med. 2014 Oct;97(10):48-9.
9
Thrombocytopenia associated with c7E3 Fab (abciximab).与c7E3 Fab（阿昔单抗）相关的血小板减少症。
Ann Hematol. 2002 Feb;81(2):76-9. doi: 10.1007/s00277-001-0414-7. Epub 2002 Jan 18.
10
The importance of differentiating ReoPro (c7E3 abciximab) induced thrombocytopenia from heparin-induced thrombocytopenia.区分瑞替普酶（c7E3阿昔单抗）诱导的血小板减少症与肝素诱导的血小板减少症的重要性。
Thromb Haemost. 1999 Nov;82(5):1560-1.

引用本文的文献

1
Integrin targeted therapeutics.整合素靶向治疗。
Theranostics. 2011 Feb 17;1:154-88. doi: 10.7150/thno/v01p0154.
2
The Optimal Route of Administration of the Glycoprotein IIb/IIIa Receptor Antagonist Abciximab During Percutaneous Coronary Intervention; Intravenous Versus Intracoronary.经皮冠状动脉介入治疗期间糖蛋白IIb/IIIa受体拮抗剂阿昔单抗的最佳给药途径；静脉注射与冠状动脉内注射对比
Curr Cardiol Rev. 2008 Nov;4(4):293-9. doi: 10.2174/157340308786349480.
3
Glycoprotein IIb/IIIa inhibitor-induced thrombocytopenia: diagnosis and treatment.
糖蛋白IIb/IIIa抑制剂所致血小板减少症：诊断与治疗
Clin Res Cardiol. 2007 Feb;96(2):61-9. doi: 10.1007/s00392-006-0459-7. Epub 2006 Dec 8.